Recall Record

Clearwater, FL, United States

Bausch & Lomb Surgical, Inc. recalls

5 recalls recorded since 2018, most recently on 6 June 2025. 2 are listed as ongoing. Status and classification are as published by the FDA.

Recalls5
Ongoing (FDA)2
Terminated or completed3
Class I (FDA)1

Ongoing Class III Medical devices

Recall started
6 June 2025
Reason
An off-power error was identified, which resulted in a diopter of 16, rather than the intended 3 diopter. Implantation of affected intraocular lens could result in functional visual impairment or reduction in visual acuity which could result in the need for optical or surgical correction.
Distribution
US: AZ, CA
Initiated
Voluntary: Firm initiated
Recall number
Z-2451-2025

Ongoing Class I Medical devices

Recall started
27 March 2025
Reason
In response to an increased number of reports of toxic anterior segment syndrome (TASS) in conjunction with implantation of enVista Aspire and enVista Envy IOLs, and certain enVista monofocal lenses in the U.S.
Distribution
Worldwide distribution. US Nationwide including PR and GU, and the countries of CAN, AUS, AUT, BEL, BGR, IC, HRV, CZE, FRA, DEU, GRC, HUN, ITA, NLD, POL, PRT, ROU, ESP, GBR, NZL, HKG.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1680-2025, Z-1679-2025

Terminated Class II Medical devices

Recall started
7 November 2020
Terminated
11 July 2024
Reason
Product may be missing toric axis marks.
Distribution
US Nationwide distribution including in the states of FL, CA, MO, MN, TN, TX, MI, WA, UT, NH, and OH.
Initiated
Voluntary: Firm initiated
Recall number
Z-0519-2021

Terminated Class II Medical devices

Recall started
9 June 2020
Terminated
11 February 2021
Reason
The toric axis marks were misaligned (from the expected position in relation to the haptics) on an implanted lens.
Distribution
U.S. Nationwide distribution including in the states of IN, SC, CT, NV, and NC.
Initiated
Voluntary: Firm initiated
Recall number
Z-2552-2020

Terminated Class II Medical devices

Recall started
5 November 2018
Terminated
4 November 2019
Reason
Cosmetic imperfections on the surface of some lenses.
Distribution
US Nationwide Distribution: AL, AR, AZ, CA, CO, CT, FL, GA, HI, IA, ID, IL IN, KS, KY, la, MA, MD, ME, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, PA, PR, SC, SD, TN, TX, UT, VA, WA, WI, WV, and WY.
Initiated
Voluntary: Firm initiated
Recall number
Z-0628-2019

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.